UniProtKB/SwissProt variant VAR

Variant information

Variant position:

430

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:

Disease [Disclaimer]

The variants are classified into three categories: Disease, Polymorphism and Unclassified.

Disease: Variants implicated in disease according to literature reports.
Polymorphism: Variants not reported to be implicated in disease.
Unclassified: Variants with uncertain implication in disease according to literature reports. Evidence against or in favor of a pathogenic role is limited and/or conflicting.

Residue change:

From Threonine (T) to Arginine (R) at position 430 (T430R, p.Thr430Arg).

Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:

Change from medium size and polar (T) to large size and basic (R)

The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:

-1

The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Involvement in disease:

Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (PVHH) [MIM:225790]: A rare prenatally lethal disorder characterized by hydranencephaly, a distinctive glomerular vasculopathy in the central nervous system and retina, and diffuse ischemic lesions of the brain stem, basal ganglia, and spinal cord with calcifications. Hydranencephaly is a condition where the greater portions of the cerebral hemispheres and corpus striatum are replaced by cerebrospinal fluid and glial tissue. {ECO:0000269|PubMed:20206334, ECO:0000269|PubMed:20518025, ECO:0000269|PubMed:20690116}. Note=The disease is caused by mutations affecting the gene represented in this entry.

The name and a short description of the disease associated with the variant. For more information about the disease, the user can refer to OMIM, following the link provided after the disease acronym.

Variant description:

In PVHH.

Any additional useful information about the variant.

Other resources:

Links to websites of interest for the variant.

Variant rs267606825 [ dbSNP | Ensembl ]

Sequence information

Variant position:

430

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:

526

The length of the canonical sequence.

Location on the sequence:

TMGFFMTGYLPLGFEFAVEL T YPESEGISSGLLNISAQVFG

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         TMGFFMTGYLPLGFEFAVELTYPESEGISSGLLNISAQVFG

Mouse                         TLGFFMTGYLPLGFEFAVEFTYPESEGVSSGLLNVSAQVFG

Rat                           SLGFFMTGYLPLGFEFAVELTYPESEGVSSGLLNVSAQVFG

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 526	Feline leukemia virus subgroup C receptor-related protein 2

Literature citations

Mutations in FLVCR2 are associated with proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (Fowler syndrome).
Meyer E.; Ricketts C.; Morgan N.V.; Morris M.R.; Pasha S.; Tee L.J.; Rahman F.; Bazin A.; Bessieres B.; Dechelotte P.; Yacoubi M.T.; Al-Adnani M.; Marton T.; Tannahill D.; Trembath R.C.; Fallet-Bianco C.; Cox P.; Williams D.; Maher E.R.;
Am. J. Hum. Genet. 86:471-478(2010)
Cited for: VARIANTS PVHH ARG-280; VAL-398 AND ARG-430;

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q9UPI3: Variant p.Thr430Arg